The Collaborative Study Group Trial: The Effect of Sulodexide in Patients With Type 2 Diabetes and Microalbuminuria

Trial Profile

The Collaborative Study Group Trial: The Effect of Sulodexide in Patients With Type 2 Diabetes and Microalbuminuria

Completed
Phase of Trial: Phase III

Latest Information Update: 12 Jun 2013

At a glance

  • Drugs Sulodexide (Primary)
  • Indications Diabetic nephropathies
  • Focus Therapeutic Use
  • Acronyms SUN-MICRO
  • Sponsors Keryx Biopharmaceuticals
  • Most Recent Events

    • 07 Mar 2008 Primary endpoint not met: results announced by Keryx.
    • 11 Feb 2008 Status changed to completed in accordance with media release 9085123.
    • 05 Dec 2007 A review by the Data Safety Monitoring Committee found no reason to recommend alteration or termination of the trial.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top